RetinalGenix Technologies (RTGN) Total Non-Current Liabilities (2022 - 2026)

RetinalGenix Technologies' (RTGN) quarterly Total Non-Current Liabilities came in at $1.7 million in Q1 2026, up 47.7% year-on-year from $1.2 million in Q1 2025, and down 5.54% quarter-over-quarter from $1.8 million in Q4 2025.

RetinalGenix Technologies (RTGN) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

RetinalGenix Technologies has disclosed Total Non-Current Liabilities across 5 years of filings, most recently posting $1.7 million for Q1 2026.

  • Total Non-Current Liabilities for Q1 2026 came in at $1.7 million, up 47.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (up 47.7% YoY), and the FY2025 annual result was $1.8 million, up 81.67% from the prior year.
  • Total Non-Current Liabilities came in at $1.7 million for Q1 2026 at RetinalGenix Technologies, down from $1.8 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $1.8 million in Q4 2025 to a low of $459804.0 in Q2 2022.
  • The 5-year median for Total Non-Current Liabilities is $1.4 million (2024), against an average of $1.3 million.
  • Across the five-year window, Total Non-Current Liabilities surged 240.79% in 2023 and decreased 14.73% in 2025, its largest moves.
  • RetinalGenix Technologies' Total Non-Current Liabilities stood at $959815.0 in 2022, then dropped by 1.2% to $948279.0 in 2023, then grew by 6.48% to $1.0 million in 2024, then surged by 81.67% to $1.8 million in 2025, then retreated by 5.54% to $1.7 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $1.7 million (Q1 2026), $1.8 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn -
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 20.94 Bn
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 40.52 Bn
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 15.78 Bn
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 2.44 Bn
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 24.21 Bn
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 9.85 Bn
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 3.53 Bn
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 3.47 Bn
10 RetinalGenix Technologies - - - 1.73 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.73 Mn
Dec 31, 2025 1.83 Mn
Sep 30, 2025 1.64 Mn
Jun 30, 2025 1.44 Mn
Mar 31, 2025 1.17 Mn
Dec 31, 2024 1.01 Mn
Sep 30, 2024 1.43 Mn
Jun 30, 2024 1.36 Mn
Mar 31, 2024 1.38 Mn
Dec 31, 2023 948,279.00
Sep 30, 2023 1.08 Mn
Jun 30, 2023 1.57 Mn
Mar 31, 2023 1.31 Mn
Dec 31, 2022 959,815.00
Jun 30, 2022 459,804.00